EUVIMEDEUVIMED entdecken
Crossref

Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization

Sunil T Galatage, Arehalli S Manjappa, Durgacharan A Bhagwat, Rahul Trivedi, Ahmad Salawi, Fahad Y Sabei, Abdullah Alsalhi

European Journal of Pharmaceutics and Biopharmaceutics · 2023-12 · 193 · 28-43

DOI: 10.1016/j.ejpb.2023.10.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023-12. Verfasst von Sunil T Galatage und 6 weiteren Autor:innen. Beteiligte Einrichtung: B. R. Nahata College of Pharmacy, Department of Pharmacy, Mandsaur University Mandsaur, Madhya Pradesh 458001, India; Vasantidevi Patil Institute of …. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Nanoparticles. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The objective of the current research work was to fabricate a fosfestrol (FST)-loaded self-nanoemulsifying drug delivery system (SNEDDS) to escalate the oral solubility and bioavailability and thereby the effectiveness of FST against prostate cancer. METHODS: 32 full factorial design was employed, and the effect of lipid and surfactant mixtures on percentage transmittance, time required for self-emulsification, and drug release were studied. The optimized solid FST-loaded SNEDDS (FSTNE) was characterized for in vitro anticancer activity and Caco-2 cell permeability, and in vivo pharmacokinetic parameters. RESULTS: Using different ratios of surfactant and co-surfactant (Km) a pseudo ternary phase diagram was constructed. Thirteen liquid nano emulsion formulations (LNE-1 to LNE-13) were formulated at Km = 3:1. LNE-9 exhibited a higher % transmittance (99.25 ± 1.82 %) and a lower self-emulsification time (24 ± 0.32 s). No incompatibility was observed in FT-IR analysis. Within 20 min the solidified FST loaded LNE-9 (FSTNE) formulation showed almost complete drug release (98.20 ± 1.30 %) when compared to marketed formulation (40.36 ± 2.8 %), and pure FST (32 ± 3.3 %) in 0.1 N HCl. In pH 6.8 phosphate buffer, the release profiles are found moderately higher than in 0.1 N HCl. FSTNE significantly (P < 0.001) inhibited the PC-3 prostate cell proliferation and also caused apoptosis (P < 0.001) compared to FST. The in vitro Caco-2 cell permeability study results revealed 4.68-fold higher cell permeability of FSTNE than FST. Remarkably, 4.5-fold rise in bioavailability was observed after oral administration of FSTNE than plain FST. CONCLUSIONS: FSTNE remarkably enhanced the in vitro anticancer activity and Caco-2 cell permeability, and in vivo bioavailability of FST. Thus, FST-SNEDDS could be utilized as a potential carrier for effective oral treatment of prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsNanoparticlesMaleHumansBiological AvailabilitySpectroscopy, Fourier Transform InfraredCaco-2 CellsDrug Delivery SystemsSolubilityDrug LiberationSurface-Active AgentsAdministration, OralEmulsionsParticle SizeDiethylstilbestrol

Stichwörter der Autor:innen

BioavailabilityFlow cytometer analysisFosfestrolMembrane potentialNano emulsionProstate cancer

Substanzen

Surface-Active AgentsEmulsionsfosfestrolDiethylstilbestrol

Autor:innen und Institutionen

  • B. R. Nahata College of Pharmacy, Department of Pharmacy, Mandsaur University Mandsaur, Madhya Pradesh 458001, India; Vasantidevi Patil Institute of Pharmacy, Kodoli 416114, Kolhapur, Maharashtra, India. Electronic addr…
  • Vasantidevi Patil Institute of Pharmacy, Kodoli 416114, Kolhapur, Maharashtra, India. Electronic address: manju_as82@yahoo.co.in.
  • Bharati Vidyapeeth College of Pharmacy, Near Chitranagari, Morewadi, Kolhapur 416013, Maharashtra, India.
  • B. R. Nahata College of Pharmacy, Department of Pharmacy, Mandsaur University Mandsaur, Madhya Pradesh 458001, India; Department of Pharmacy, Sumandeep Vidyapeeth University, Vadodara 391760, Gujrat, India.
  • Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.

Zitieren

APA

Galatage, S. T., Manjappa, A. S., Bhagwat, D. A., Trivedi, R., Salawi, A., Sabei, F. Y., & Alsalhi, A. (2023). Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization. European Journal of Pharmaceutics and Biopharmaceutics, 193, 28-43. https://doi.org/10.1016/j.ejpb.2023.10.013

Vancouver

Galatage ST, Manjappa AS, Bhagwat DA, Trivedi R, Salawi A, Sabei FY, et al. Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization. European Journal of Pharmaceutics and Biopharmaceutics. 2023;193:28-43. doi:10.1016/j.ejpb.2023.10.013

BibTeX
@article{Galatage2023,
  author = {Galatage, Sunil T and Manjappa, Arehalli S and Bhagwat, Durgacharan A and Trivedi, Rahul and Salawi, Ahmad and Sabei, Fahad Y and Alsalhi, Abdullah},
  title = {Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2023},
  volume = {193},
  pages = {28--43},
  doi = {10.1016/j.ejpb.2023.10.013}
}
Kostenlos starten →